tirzepatide stacked with retatrutide vs Compared Retatrutide vs Tirzepatide: a Quick

Infectious Diseases Society of A

At Viome, we believe true health begins within

Lehmann R, Zhao X, Weigert C, Simon P, Fehrenbach E, Fritsche J, et al

The initial dose is 25 mg daily, which can be increased up to a maximum of 200 mg as prescribed

Key safety observations from available trial data include: Elevated resting heart rate in a dose-dependent manner Gastrointestinal adverse effects (nausea, vomiting, diarrhoea) as the most common side effects, consistent with the GLP-1 receptor agonist class [1] [3] No clinically significant QT interval prolongation was reported in available data, though the extent of formal thorough QT assessment has not been fully detailed in published sources

And with more GLP-1s expected to enter the market soon, there will be downward price pressure over the next few years